Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › FDA Approves Perjeta For Neoadjuvant Breast Cancer Treatment

 

FDA Approves Perjeta For Neoadjuvant Breast Cancer Treatment

2013-10-02 06:33:29| drugdiscoveryonline News Articles

The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer

Tags: treatment cancer breast breast cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

25.09 Maxcess announces launch of new Tidland slitting system 25.09 AkzoNobel Helps Consumer Electronics Industry to Use More Recycled Plastics 25.09 Sherwin-Williams Interior Paint Earns Top Honors from J.D. Power 25.09 Hurricane Helene Probabilistic Storm Surge Graphics 25.09 AkzoNobel Helps Consumer Electronics Industry to Use More Recycled Plastics 25.09 Tnemec Announces New Technical Marketing Manager 25.09 Petrol prices fall to lowest for three years 25.09 Hurricane Helene Graphics More »